EMERYVILLE, Calif. & SAN FRANCISCO--(BUSINESS WIRE)-- Amyris, Inc. (NASDAQ:AMRS), a leading renewable chemicals and fuels company, and Method Products, Inc., the leading innovator in premium, environmentally-conscious household and personal care products, have signed a Joint Development Agreement to generate a portfolio of novel molecules from Biofene, Amyris renewable farnesene made from plant sugars, for use in Method’s products.
Under the agreement, Amyris and Method will collaborate to evaluate and develop multiple ingredients, such as surfactants and solvents, derived from Biofene, to deliver environmentally-friendly products with uncompromising performance. Upon successful development of an ingredient and incorporation into a Method product, Amyris and Method will pursue a supply agreement for Amyris to supply the ingredient to Method for use in its products.
“For more than a decade, Method has been bringing innovative and sustainable products to the cleaning and personal care sectors,” says Adam Lowry, Method co-founder and Chief Greenskeeper. “Our partnership with Amyris gives us the unprecedented opportunity to develop entirely new molecules that take our already industry leading technology to the next level. The ingredients we are developing deliver never-seen-before performance in a cleaning product of any kind, yet these are ingredients made from natural, renewable, and sustainable sources.”
“Amyris is committed to bringing innovative, sustainable products to the consumer packaged goods market. By eliminating any tradeoffs in performance for renewability, Amyris and Method can jointly grow consumer adoption of renewable products,” said John Melo, CEO of Amyris. “This partnership with Method validates the potential of Biofene to produce high-performance replacements for petrochemical ingredients in the consumer packaged goods industry, expands the market opportunity for Biofene, and provides another route to market for Amyris products.”
Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules - flexible building blocks that can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels, LLC. For more information, visit www.amyris.com.
Founded in 2000, Method is headquartered in San Francisco, Calif. Method is the leading innovator of premium healthy home and personal care products and can be found in more than 35,000 retail locations throughout North America, Europe, Australia and Asia. Major national retailers include Target, Whole Foods, Lowe’s Home Improvement Centers, Bed Bath & Beyond, Wegman’s and Safeway,Method is a privately held company backed by San Francisco Equity Partners, Simon Equity Partners, and private individual investors. For more information, visit methodhome.com.
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the parties’ ability to successfully develop and commercialize Biofene derivatives for, and the commercial acceptance and performance of such derivatives in, the household and consumer packaged goods markets) that involve risks and uncertainties. These statements are based on management’s current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, our reliance on third parties to achieve our goals, and other risks detailed in the “Risk Factors” sections of Amyris’s annual report on Form 10-K filed on March 14, 2011 and quarterly reports on Form 10-Q filed on May 11, 2011 and August 11, 2011. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, No Compromise and Biofene are trademarks or registered trademarks of Amyris, Inc.